Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritis

Quan Qiu1, Ze Zheng, Lin Chang

  • 1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

The EMBO Journal
|August 15, 2013
PubMed

Insights

In rheumatoid arthritis, inositol-requiring enzyme 1α (IRE1α) drives inflammation by promoting cytokine production. Inhibiting IRE1α reduced joint inflammation in mouse models, highlighting its potential as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) involves macrophages releasing inflammatory mediators.
  • Toll-like receptor (TLR)-mediated signaling in macrophages drives cytokine production in RA.
  • The unfolded protein response (UPR) transducer, inositol-requiring enzyme 1α (IRE1α), is implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the role of IRE1α in macrophage activation and inflammatory cytokine production in rheumatoid arthritis.
  • To explore the regulatory mechanisms of IRE1α activation in response to TLR signaling.
  • To evaluate IRE1α as a potential therapeutic target for inflammatory arthritis.

Main Methods:

  • Analysis of IRE1α activation in macrophages from RA patients' synovial fluid.
  • Utilizing myeloid-specific IRE1α knockout mice to assess its role in inflammatory arthritis.
  • Employing an IRE1α-specific inhibitor (4U8C) in mouse models of joint inflammation.
  • Investigating the interaction between TRAF6, PP2A, and IRE1α in TLR-mediated signaling.

Main Results:

  • Macrophages from RA patients showed increased IRE1α activation.
  • Myeloid-specific deletion of IRE1α protected mice from inflammatory arthritis.
  • Treatment with the IRE1α inhibitor 4U8C reduced joint inflammation in mice.
  • IRE1α deficiency impaired TLR-induced pro-inflammatory cytokine production in macrophages and neutrophils.
  • TRAF6-mediated ubiquitination of IRE1α was identified as a key mechanism for its activation, preventing inhibition by PP2A.

Conclusions:

  • IRE1α plays a critical role in regulating TLR-induced pro-inflammatory cytokine production.
  • The TRAF6-IRE1α axis is a novel regulatory pathway in inflammatory responses.
  • IRE1α represents a promising therapeutic target for managing inflammatory arthritis.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...